Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11851493 Trispecific antagonists

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jackie Sheng0

Bo Liu0

Date of Patent

December 26, 2023

0

Patent Application Number

169954140

Date Filed

August 17, 2020

0

Patent Citations

US Patent 8992913 Antagonist antibodies against GDF-8 and uses therefor

0

US Patent 9890204 Trivalent, bispecific antibodies

0

US Patent 9987500 Human antibodies to PD-1

0

US Patent 9994632 Humanized or affinity-matured anti Ang-2 antibody and uses thereof

0

US Patent 10112997 Tight-binding agents and uses thereof

0

US Patent 10189902 Antibodies to TIGIT

0

US Patent 6884879 Anti-VEGF antibodies

0

US Patent 7025962 Mammalian cell surface antigens; related reagents

0

...

Patent Primary Examiner

Meera Natarajan

0

Patent abstract

Antitumor antagonists that bind specifically to immune checkpoint regulator and/or components of the angiogenesis pathways and/or components of the TGF pathway are disclosed. Also disclosed is a method of treating proliferative disorders with the antitumor antagonists.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11851493 Trispecific antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool